Navigation Links
Agile Therapeutics Abstracts on Lead Product, AG200-15 Accepted by ACOG
Date:12/9/2008

>Ovulation Suppression and Cycle Control of Ethinyl Estradiol and Levonorgestrel Combination Patches, authored by Daniel R. Mishell Jr., M.D., David F. Archer, M.D., Arkady Rubin, Ph.D., Marie Foegh, M.D., DrSc, to be presented on Tuesday, May 5.

Marie Foegh, M.D., DrSc, Vice President, Clinical Research and Development at Agile Therapeutics, Inc., commented, "We are very excited to be working closely with leaders in the field of women's reproductive health, including David Archer M.D., Daniel Mishell M.D., and Frank Stancyk Ph.D., and to share positive safety and efficacy data on this important new entry into the contraceptive market."

Daily oral contraceptives and condoms are currently the most popular methods of birth control. In a 500 patient survey, sponsored by Agile, a weekly contraceptive patch was preferred over the pill by a 4-to-1 margin by women desiring contraception. Interest in an alternative to the daily birth control pill was also seen in another Agile-sponsored survey of 1,000 women using or desiring contraception. In that study, more than half of the women surveyed said they would ask their doctor about AG200-15, a low-dose, weekly contraceptive patch, after reading its profile.

About AG200-15, Agile's Low-Dose Contraceptive Patch

AG200-15 with SKINFUSION(TM) technology is a low-dose, weekly contraceptive patch that is entering Phase 3 development with a clearly defined regulatory pathway. SKINFUSION(TM) technology makes it possible to utilize the trusted hormone combination of levonorgestrel and ethinyl estradiol in a contraceptive patch. The patch was designed for flexibility and comfort.

About Estrogen

Estrogen is associated with certain side effects, such as breast tenderness, bloating/weight gain, nausea and vomiting. These side effects are believed to be related to the amount of hormones delivere
'/>"/>

SOURCE Agile Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. $21.8 Million NIH Grant for Fragile X Research
2. Stem cell research produces a key discovery for Fragile X Syndrome
3. Brain Defect Helps Drive Fragile X Syndrome
4. Fragile X Foundations Sign Merger Agreement
5. Fragile X Syndrome Corrected in Mice
6. Drosophila drug screen for fragile X syndrome finds promising compounds and potential drug targets
7. Prime Therapeutics Receives TIPPS Certification
8. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
9. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
10. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
11. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/18/2010)... Taxes, Other Tobacco Prevention Initiatives , ... , , ... ... ... WASHINGTON , March 18 Kids in New Jersey will take center stage in the fight against tobacco on March ...
(Date:3/18/2010)... ... , , ... ... ... New Hampshire will take center stage in the fight against tobacco on March 24 as they join thousands of young people nationwide ...
(Date:3/18/2010)... President and CEO, Legacy(SM) , ... , , ... ... WASHINGTON , March ... ...
(Date:3/18/2010)... of U.S. medical students choosing internal medicine residencies ... significantly impact the shortage of primary care physicians. ... Program report, 2,722 U.S. seniors at medical schools ... 3.4 percent increase from 2,632 in 2009. The ... (2,660), 2007 (2,680), and 2006 (2,668). In comparison, ...
(Date:3/18/2010)... In its 21-year history, under the ... leaders, SRLA has trained more than 40,000 teenagers from ... area to complete the 26.2 mile Los Angeles Marathon. ... volunteer leaders will again participate in the LA Marathon. ... SRLA,s mission is to challenge at-risk secondary students to ...
Breaking Medicine News(10 mins):Health News:New Jersey Kids 'Kick Butts' on March 24 2Health News:New Jersey Kids 'Kick Butts' on March 24 3Health News:New Jersey Kids 'Kick Butts' on March 24 4Health News:New Jersey Kids 'Kick Butts' on March 24 5Health News:New Hampshire Kids 'Kick Butts' on March 24 2Health News:New Hampshire Kids 'Kick Butts' on March 24 3Health News:New Hampshire Kids 'Kick Butts' on March 24 4Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 2Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 3Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 4Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 5Health News:Residency match results not encouraging for adults needing primary care 2Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 2Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 3
... Dr. Quansheng Du wants to make sure both offspring do ... that enables one cell to become two. , When all ... organ or replenish endogenous stem cells. , When it goes ... What we are trying to understand is how cells divide, ...
... have developed a sensor system that continuously monitors the ... the pockets of a vest, the new system could ... We are investigating whether we can go back after ... environmentally when the attack started, said Charlene Bayer, a ...
... and Northwestern University have developed a localized and ... the immune system, a discovery that could provide ... other diseases. , The study, published Jan. 22, ... example of the enormous potential and clinical significance ...
... knows that overweight people have a higher risk of heart attacks, ... people who carry their extra weight around their waist giving ... highest risk of all. , But despite the impact on human ... fat also known as visceral fat -- have eluded scientists. ...
... Genetic Medicine (IGM) at Johns Hopkins will join other ... an ambitious effort that will involve sequencing the genomes ... the most detailed and medically useful picture to date ... headway in creating a map of common DNA variation ...
... of Drug-Eluting Stents, HOLLYWOOD, Fla., Jan. 21 ... shows promise in opening and healing blocked heart,arteries ... a study being presented at the 20th annual ... coating is 25,000 times thinner than a human ...
Other Medicine News:Health News:Cell division studies hint at future cancer therapy 2Health News:Cell division studies hint at future cancer therapy 3Health News:Investigating causes of asthma attacks: New sensor system monitors environmental exposure 2Health News:Scientists use nanomaterials to localize and control drug delivery 2Health News:Scientists use nanomaterials to localize and control drug delivery 3Health News:The missing link between belly fat and heart disease? 2Health News:The missing link between belly fat and heart disease? 3Health News:The missing link between belly fat and heart disease? 4Health News:Johns Hopkins to participate in 1000 Genomes Project 2Health News:Super-Thin Drug-Free Coating 'Hides' Stent as It Unblocks Heart Arteries 2Health News:Super-Thin Drug-Free Coating 'Hides' Stent as It Unblocks Heart Arteries 3Health News:Super-Thin Drug-Free Coating 'Hides' Stent as It Unblocks Heart Arteries 4
(Date:3/18/2010)... March 18 Poniard Pharmaceuticals, Inc. ... innovative oncology therapies, today announced that the U.S. Patent ... the composition of matter patent for picoplatin as RE41209, ... 2010 . The reissue was applied for May ... , the USPTO released the "Issue Notification" for the ...
(Date:3/18/2010)... , March 18 ... Chief Executive Officer, Pfizer, was elected board ... of America (PhRMA) today at the trade ... Chief Executive Officer Christopher Viehbacher ... Directors, and John C. Lechleiter , ...
(Date:3/18/2010)... results in too much ammonia in the blood. , ... , , ... ... (Logo: ... ...
Breaking Medicine Technology:U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 2U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 3U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 4U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 5Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 2Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 3Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 4Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 5Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 6Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 7Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 8FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 2FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 3FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 4FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 5Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 1Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 2Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 3Exposure to lead tobacco smoke raises risk of ADHD 10856 1Exposure to lead tobacco smoke raises risk of ADHD 10856 2Measuring and modeling blood flow in malaria 61892 1Measuring and modeling blood flow in malaria 61892 2
... Ill., Oct. 25 Astellas Pharma US, ... hydrochloride,injection) effectively raises serum sodium concentration ([Na+]) ... or hypervolemic,hyponatremia, a potentially life-threatening condition that ... normal. The efficacy and safety profile of,VAPRISOL ...
... Genaera,Corporation (Nasdaq: GENR ) is providing the ... 1 study of trodusquemine and,additional preclinical data expanding the ... models from the North American,Association for the Study of ... Interim results from Study MSI-1436C-101 presented at Genaera,s poster ...
Other Medicine Technology:Study Shows VAPRISOL(R) is Effective in Increasing Serum Sodium Levels and Well-Tolerated in Patients With Euvolemic or Hypervolemic Hyponatremia 2Study Shows VAPRISOL(R) is Effective in Increasing Serum Sodium Levels and Well-Tolerated in Patients With Euvolemic or Hypervolemic Hyponatremia 3Study Shows VAPRISOL(R) is Effective in Increasing Serum Sodium Levels and Well-Tolerated in Patients With Euvolemic or Hypervolemic Hyponatremia 4Study Shows VAPRISOL(R) is Effective in Increasing Serum Sodium Levels and Well-Tolerated in Patients With Euvolemic or Hypervolemic Hyponatremia 5Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting 4Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting 5Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting 6
... ideally suited to continuously monitor the areas ... and blood banks. In addition, CIMScan ... of the physical plant as well. The ... handled over the hospital's existing LAN. Maintenance ...
GelPort hand access laparoscopy combines the patient outcomes of minimally invasive surgery with the speed and precision of open surgery....
... The HandPort Systems non-adhesive sealing ... Hand-Assisted Laparoscopic Surgrery (HALS) procedures, ... grasp, and palpate throughout. Because ... as 6 cm, patients experience ...
... Disc is a Hand Assisted Laparoscopic Surgery ... the surgeons hand may facilitate the procedure, ... has applications in colorectal, urological and general ... extracorporeal extension of pneumoperitoneum and abdominal access ...
Medicine Products: